View Future GrowthBespoke Extracts 과거 순이익 실적과거 기준 점검 0/6Bespoke Extracts은 연평균 17.7%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 9.4%의 비율로 증가했습니다. 매출은 연평균 69.8%의 비율로 증가했습니다.핵심 정보17.68%순이익 성장률54.25%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률5.95%매출 성장률69.76%자기자본이익률n/a순이익률-51.34%최근 순이익 업데이트30 Sep 2025최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 19Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/18/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.공시 • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.공시 • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.공시 • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.공시 • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.공시 • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.공시 • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.공시 • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.공시 • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.공시 • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.매출 및 비용 세부 내역Bespoke Extracts가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:BSPK 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Sep 251-11030 Jun 251-11031 Mar 251-11031 Dec 241-11030 Sep 241-12030 Jun 241-12031 Mar 241-12031 Dec 231-12030 Sep 231-22030 Jun 230-33031 Mar 230-44031 Dec 220-44030 Sep 220-33030 Jun 220-22031 Mar 220-12031 Dec 21001030 Nov 210-11031 Aug 210-11031 May 210-11028 Feb 210-44031 Dec 200-11030 Nov 200-44031 Aug 200-54031 May 200-54029 Feb 200-21030 Nov 190-21031 Aug 1903-3031 May 1901-1028 Feb 190-11030 Nov 180-32031 Aug 180-87031 May 180-76028 Feb 180-99030 Nov 170-88031 Aug 170-77031 May 170-55028 Feb 17000030 Nov 16000031 Aug 16000031 May 160-10029 Feb 160-10030 Nov 150-10031 Aug 150-100양질의 수익: BSPK 은(는) 현재 수익성이 없습니다.이익 마진 증가: BSPK는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: BSPK는 수익성이 없지만 지난 5년 동안 연평균 17.7%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 BSPK의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: BSPK은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(-4.8%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: BSPK의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/26 21:53종가2026/05/26 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bespoke Extracts, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 19Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/18/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
공시 • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.
공시 • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.
공시 • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.
공시 • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.
공시 • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.
공시 • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.
공시 • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.
공시 • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.
공시 • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.